We would love to hear your thoughts about our site and services, please take our survey here.
Their last half yearly report states total asset value in Hong Kong & Mainland China of (£1,249.9 million), and that was before they sold this latest asset for more than they expected. This does look undervalued? Or is there something i'm missing..
Latest trading statement does look positive.. It states "Positive Profit Alert" However at the bottom it states "Shareholders and potential investors are advised to exercise caution when dealing in the shares of the Company."
Isn't this the key section "After repayment of the Bank Loan with a principal amount of approximately HK$1,981 million (approximately £183 million), the AGP Group will receive a net consideration for the Sale Shares of approximately HK$8,019 million (approximately £743 million) and together with the Capex Amount and the Owner's Fund, a total net consideration of approximately HK$8,144 million (approximately £754 million), before deducting transaction costs and expenses. The capital gain from the Disposal before transaction costs and expenses is expected to be approximately HK$700 million (approximately £65 million)." Total Net Consideration: £754m Capital Gain: £65m
Fund owns over 5.30% here http://www.hl.co.uk/funds/fund-discounts,-prices--and--factsheets/search-results/m/marlborough-uk-micro-cap-growth-class-p-accumulation/charts
Holdings in Argos Resources Ltd ("Argos") & FOGL 22.5m shares in issue Future profits to be based on share performance of above companies? Anyway, I don't think it looks like MMs have any shares at all, this will bounce
Indeed. However there will be a lot of people still tied into contracts, whether this has breeched them and they can cancel? Doubt it. Could be 6 to 12 months before dropping below the 200 mark. But a good long term short no doubt, if you're happy for a bit of a ride and broker daily over night fees.
Just looking at those figures makes this feel a bit pumpy unless there is some kind of deal in anticipation? #IRG joint acquisition of producing well in Egypt is expected anyday - re-rate coming there for us only £1.4m MCAP
As a result of the reduced contract base and restructuring costs incurred during the downscale of operations the Company experienced comprehensive losses during H1 2015 of US$2.6 million At 30 June 2015 the Company had cash and cash equivalents of US$6.1m. $2.6m loss a Half, means $6.1m will last just over a year........
I was reading today "If certain milestones are achieved Tiziana will also pay one per cent of its enterprise value to the University in the event of a trade sale of Tiziana to a third party." Current Mcap - £225m Anti-cancer drug worth...?
When did you buy in scoopy?
XICO sells technologies and services for the analysis of brain disease. We expect strong growth mainly driven by the expansion of its clinical trial business into new indications new markets and bigger contracts. It is also well placed to capitalise on the burgeoning use of digital technologies in disease management. Using DCF we value IXICO at £10.7m or 62p/share. More: http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=117321#.VcSLF_lVhBd#ixzz3i7mzzlYi
I think investors are missing the inherent value of this company. Stock market value is appx £5.12 million, it has cash of appx £1.95 million. Taking out the cash element the business is valued valued at just £3.17 million This value does not reflect the enormous potential here - they are aiming to deliver the use of their diagnostic kit around the globe with major pharmaceutical companies, and are pretty much already firmly on the way to that. Compare the value of IXICO to other similar companies and you will see a multiples of IXCO's value THE SHARE WLL NOT REMAIN AT THIS LEVEL FOR LONG